TY - JOUR
T1 - Incomplete Dll4/Notch signaling inhibition promotes functional angiogenesis supporting the growth of skin papillomas
AU - Djokovic, Dusan
AU - Trindade, Alexandre
AU - Gigante, Joana
AU - Pinho, Mario
AU - Harris, Adrian L.
AU - Duarte, Antonio
N1 - Publisher Copyright:
© 2015 Djokovic et al.
PY - 2015/8/28
Y1 - 2015/8/28
N2 - Background: In invasive malignancies, Dll4/Notch signaling inhibition enhances non-functional vessel proliferation and limits tumor growth by reducing its blood perfusion. Methods: To assess the effects of targeted Dll4 allelic deletion in the incipient stages of tumor pathogenesis, we chemically induced skin papillomas in wild-type and Dll4 +/- littermates, and compared tumor growth, their histological features, vascularization and the expression of angiogenesis-related molecules. Results: We observed that Dll4 down-regulation promotes productive angiogenesis, although with less mature vessels, in chemically-induced pre-cancerous skin papillomas stimulating their growth. The increase in endothelial activation was associated with an increase in the VEGFR2 to VEGFR1 ratio, which neutralized the tumor-suppressive effect of VEGFR-targeting sorafenib. Thus, in early papillomas, lower levels of Dll4 increase vascularization through raised VEGFR2 levels, enhancing sensitivity to endogenous levels of VEGF, promoting functional angiogenesis and tumor growth. Conclusion: Tumor promoting effect of low-dosage inhibition needs to be considered when implementing Dll4 targeting therapies.
AB - Background: In invasive malignancies, Dll4/Notch signaling inhibition enhances non-functional vessel proliferation and limits tumor growth by reducing its blood perfusion. Methods: To assess the effects of targeted Dll4 allelic deletion in the incipient stages of tumor pathogenesis, we chemically induced skin papillomas in wild-type and Dll4 +/- littermates, and compared tumor growth, their histological features, vascularization and the expression of angiogenesis-related molecules. Results: We observed that Dll4 down-regulation promotes productive angiogenesis, although with less mature vessels, in chemically-induced pre-cancerous skin papillomas stimulating their growth. The increase in endothelial activation was associated with an increase in the VEGFR2 to VEGFR1 ratio, which neutralized the tumor-suppressive effect of VEGFR-targeting sorafenib. Thus, in early papillomas, lower levels of Dll4 increase vascularization through raised VEGFR2 levels, enhancing sensitivity to endogenous levels of VEGF, promoting functional angiogenesis and tumor growth. Conclusion: Tumor promoting effect of low-dosage inhibition needs to be considered when implementing Dll4 targeting therapies.
UR - http://www.scopus.com/inward/record.url?scp=84940029939&partnerID=8YFLogxK
U2 - 10.1186/s12885-015-1605-2
DO - 10.1186/s12885-015-1605-2
M3 - Article
C2 - 26314892
AN - SCOPUS:84940029939
SN - 1471-2407
VL - 15
JO - BMC Cancer
JF - BMC Cancer
IS - 1
M1 - 608
ER -